|
|
|
|
|
| |
| |
Kendle Early Stage - Toronto (formerly DecisionLine), a contract research organization, provides early stage development expertise to pharmaceutical and biotechnology companies. While experienced with many therapeutic areas, we have significant domain expertise on measuring the drug effect of CNS products.
By delivering science-driven solutions to complex safety and pharmacologic profile study needs, Kendle Early Stage - Toronto can help enable more confident decisions to advance compound development.
Kendle Early Stage - Toronto is committed to working with our clients to achieve the highest standards by operating on the basis of the following four tenets:
 |
Through our proprietary, 21 CFR Part 11 validated software system, we can measure a wide range of pharmacodynamic endpoints critical to many early phase studies, including Abuse Liability, Alcohol and Drug-Drug Interactions, and Neurocognitive Assessment.
|
 |
Kendle Early Stage - Toronto’s internationally recognized Clinical Pharmacology Group has the experience needed to provide value-added solutions to overcome early stage challenges. |
 |
Kendle Early Stage - Toronto has proven full service skills in the design, conduct and analysis of clinical trials. These capabilities ensure the seamless execution of your study from concept to final report - Learn more
|
 |
To ensure on budget study conduct, Kendle Early Stage - Toronto deploys a sponsor-centric project management system. Lead by experienced Project Managers, our integrated teams understand the importance of delivering clean data in a timely manner - Learn more
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|